February 2, 2010 - Among noninvasive imaging tests for ruling out coronary artery disease (CAD), computed tomography (CT) is a more accurate noninvasive test than magnetic resonance imaging (MRI), according to a comparative study released in Annals of Internal Medicine.

CAD is a major cause of death in the United States. Typically, CAD is diagnosed through conventional coronary angiography. However, this technique is invasive and potentially risky. As multislice CT and MRI have become more widely adopted for noninvasive coronary angiography, researchers wanted to compare CT and MRI for ruling out clinically significant coronary artery disease CAD.

Researchers reviewed studies that compared CT (89 studies) or MRI (20 studies) to conventional coronary angiography in patients with suspected or known CAD. The studies were comprised of 7,516 and 989 patients, respectively. The researchers found that for ruling out CAD, CT is a more accurate noninvasive test than MRI.

It is important to note that only a few of the studies investigated coronary angiography with MRI. Only five studies were direct head-to-head comparisons of CT and MRI. Covariate analyses explained only part of the observed heterogeneity.

The investigators concluded that for ruling out CAD, CT is more accurate than MRI. Scanners with more than 16 rows improve sensitivity, as do slowed heart rates.

Reference: Schuetz, G; Zacharopoulou, NM; Schlattmann, P; Dewey, M.Noninvasive Coronary Angiography Using Computed Tomography Versus Magnetic Resonance Imaging. Annals of Internal Medicine. Feb. 2, 2010 152:167-177.

For more information: www.annals.org


Related Content

News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
Subscribe Now